Leadership changes

Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.

Updated Nov 10, 2026

Changes, November 2026

429

Appointments

211

Departures

Browse by role

Get new CFO appointments the day the filing lands.

Start alerts

Browse by month

Leadership changes
Filing date	Company	Person	Role	Change	Effective date	Source
Nov 2, 2026	ZIPRECRUITER, INC.	Emily McEvilly	Board of DirectorsBoard of Directors	Departed	Oct 29, 2026	SEC 8-K
Nov 2, 2026	ZIPRECRUITER, INC.	Jeffrey Liaw	Class III directorClass III director	Appointed	Oct 29, 2026	SEC 8-K
Nov 3, 2026	ACCENDRA HEALTH INC/VA/	Perry A. Bernocchi	Executive Vice President, Chief Operating OfficerCOO	Departed	Oct 29, 2026	SEC 8-K
Nov 3, 2026	ACM Research, Inc.	Yue Ma	Chief Operations OfficerCOO	Appointed	Oct 1, 2026	SEC 8-K
Nov 3, 2026	Alamar Biosciences, Inc.	Timothy “Tod” White	PresidentPresident	Departed	Dec 31, 2026	SEC 8-K
Nov 3, 2026	ANAVEX LIFE SCIENCES CORP.	Terrie Kellmeyer, Ph.D.	Chief Executive OfficerCEO	Appointed	Nov 1, 2026	SEC 8-K
Nov 3, 2026	ASTEC INDUSTRIES INC	Linda Knoll	DirectorDirector	Departed	Dec 14, 2026	SEC 8-K
Nov 3, 2026	ASTEC INDUSTRIES INC	John Keating	member of the Boardmember of the Board	Appointed	Dec 11, 2026	SEC 8-K
Nov 3, 2026	BGC Group, Inc.	JP Aubin	Vice ChairmanVice Chairman	Appointed	Dec 31, 2026	SEC 8-K
Nov 3, 2026	BGC Group, Inc.	JP Aubin	Co-CEOCEO	Departed	Dec 31, 2026	SEC 8-K
Nov 3, 2026	BNB Standard Corp	Anthony Scaramucci	directordirector	Appointed	Nov 3, 2026	SEC 8-K
Nov 3, 2026	CHEGG, INC	Marcela Martin	member of the Board of Directorsmember of the Board of Directors	Departed	Dec 10, 2026	SEC 8-K
Nov 3, 2026	Concentrix Corp	Chinnu Susan Varghese	Chief Financial OfficerCFO	Appointed	Dec 1, 2026	SEC 8-K
Nov 3, 2026	Concentrix Corp	Andre Valentine	Chief Financial OfficerCFO	Departed	Dec 1, 2026	SEC 8-K
Nov 3, 2026	Concord Acquisition Corp II	Michele Cito	Chief Financial OfficerCFO	Departed	Oct 28, 2026	SEC 8-K
Nov 3, 2026	Concord Acquisition Corp II	Charles Coop	Chief Financial OfficerCFO	Appointed	Oct 28, 2026	SEC 8-K
Nov 3, 2026	ELITE PHARMACEUTICALS INC /NV/	Aqeel A. Fatmi, Ph.D.	Class II directorClass II director	Appointed	Oct 28, 2026	SEC 8-K
Nov 3, 2026	ELITE PHARMACEUTICALS INC /NV/	John W. LaRocca, Esq.	Class I directorClass I director	Appointed	Oct 28, 2026	SEC 8-K
Nov 3, 2026	Enovix Corp	Arthi Chakravarthy	Chief Legal Officer and Corporate SecretaryCLO	Departed	Oct 30, 2026	SEC 8-K
Nov 3, 2026	ERIE INDEMNITY CO	Timothy G. NeCastro	President and Chief Executive OfficerCEO	Departed	Nov 2, 2026	SEC 8-K

Sort:Filing date ↑Company Role

ZIPRECRUITER, INC.Departed
Emily McEvilly Board of Directors
Filed Nov 2, 2026Effective Oct 29, 2026SEC 8-K
ZIPRECRUITER, INC.Appointed
Jeffrey Liaw Class III director
Filed Nov 2, 2026Effective Oct 29, 2026SEC 8-K
ACCENDRA HEALTH INC/VA/Departed
Perry A. Bernocchi COO
Filed Nov 3, 2026Effective Oct 29, 2026SEC 8-K
ACM Research, Inc.Appointed
Yue Ma COO
Filed Nov 3, 2026Effective Oct 1, 2026SEC 8-K
Alamar Biosciences, Inc.Departed
Timothy “Tod” White President
Filed Nov 3, 2026Effective Dec 31, 2026SEC 8-K
ANAVEX LIFE SCIENCES CORP.Appointed
Terrie Kellmeyer, Ph.D. CEO
Filed Nov 3, 2026Effective Nov 1, 2026SEC 8-K
ASTEC INDUSTRIES INCDeparted
Linda Knoll Director
Filed Nov 3, 2026Effective Dec 14, 2026SEC 8-K
ASTEC INDUSTRIES INCAppointed
John Keating member of the Board
Filed Nov 3, 2026Effective Dec 11, 2026SEC 8-K
BGC Group, Inc.Appointed
JP Aubin Vice Chairman
Filed Nov 3, 2026Effective Dec 31, 2026SEC 8-K
BGC Group, Inc.Departed
JP Aubin CEO
Filed Nov 3, 2026Effective Dec 31, 2026SEC 8-K
BNB Standard CorpAppointed
Anthony Scaramucci director
Filed Nov 3, 2026Effective Nov 3, 2026SEC 8-K
CHEGG, INCDeparted
Marcela Martin member of the Board of Directors
Filed Nov 3, 2026Effective Dec 10, 2026SEC 8-K
Concentrix CorpAppointed
Chinnu Susan Varghese CFO
Filed Nov 3, 2026Effective Dec 1, 2026SEC 8-K
Concentrix CorpDeparted
Andre Valentine CFO
Filed Nov 3, 2026Effective Dec 1, 2026SEC 8-K
Concord Acquisition Corp IIDeparted
Michele Cito CFO
Filed Nov 3, 2026Effective Oct 28, 2026SEC 8-K
Concord Acquisition Corp IIAppointed
Charles Coop CFO
Filed Nov 3, 2026Effective Oct 28, 2026SEC 8-K
ELITE PHARMACEUTICALS INC /NV/Appointed
Aqeel A. Fatmi, Ph.D. Class II director
Filed Nov 3, 2026Effective Oct 28, 2026SEC 8-K
ELITE PHARMACEUTICALS INC /NV/Appointed
John W. LaRocca, Esq. Class I director
Filed Nov 3, 2026Effective Oct 28, 2026SEC 8-K
Enovix CorpDeparted
Arthi Chakravarthy CLO
Filed Nov 3, 2026Effective Oct 30, 2026SEC 8-K
ERIE INDEMNITY CODeparted
Timothy G. NeCastro CEO
Filed Nov 3, 2026Effective Nov 2, 2026SEC 8-K